The DOI matches its Crossref record; the references it cites are not checked yet.
Past and Future. Current Drugs Targeting HIV-1 Integrase and Reverse Transcriptase-Associated Ribonuclease H Activity: Single and Dual Active Site Inhibitors
Open accessAbstract
Catalytic HIV type-1 (HIV-1) integrase (IN) and ribonuclease H (RNase H) domains belong to the polynucleotidyl transferase superfamily and are characterized by highly conserved motifs that coordinate two divalent Mg 2+ cations and are attractive targets for new antiviral agents. Several structural features of both domains are now available. Drugs targeting the HIV-1 IN are currently approved for anti-HIV therapy, while no drug targeting the HIV-1 RNase H function is yet available. This review describes HIV-1 IN and the RNase H function and structures, compounds targeting their active sites and dual inhibition as a new approach for drug development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diketo acid, N-hydroxyimide and hydroxytropolone exhibit INST inhibition as well as RNH inhibition, as explained in a recent review article [34].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [34]
In the citing paper
“During the past several years, significant progress has been made in the development of active-site RNH inhibitors [32-35].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [34]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 109 · Cited by 68
Research works printed but not linked: 2
- Billich A, 2003, Curr Opin Investig Drugs, 4, 206
- Fantauzzi A, 2013, HIV AIDS (Auckl), 5, 29
Metadata
- Authors
- Esposito, F., & Tramontano, E.
- Affiliations
- University of Cagliari (IT)
- Venue
- Antiviral Chemistry and Chemotherapy
- Publisher
- SAGE Publications
- Published
- 2014-08
- Volume
- 23
- Issue
- 4
- Pages
- 129-144
- ISSN
- 0956-3202 (ISSN-L)
- 2040-2066
- OpenAlex
- W2003586359
- Cited by
- 68
- References
- 109
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 5 · 2016: 9 · 2015: 5 · 2014: 6
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Antiviral chemistry & chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Keywords
- HIV-1 integrase, RNase H, HIV-1 reverse transcriptase, integrase inhibitors, RNase H inhibitors, antiviral drug discovery, Mg2+ coordination, protein structure
- MeSH terms
- Humans, Models, Molecular, HIV-1, HIV Infections, Ribonuclease H, HIV Integrase, HIV Integrase Inhibitors, Catalytic Domain, HIV Reverse Transcriptase, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Past and Future. Current Drugs Targeting HIV-1 Integrase and Reverse Transcriptase-Associated Ribonuclease H Activity: Single and Dual Active Site Inhibitors. https://app.cochat.ai/papers/10.3851/imp2690
- The paper
- Esposito, F., & Tramontano, E. (2014). Past and Future. Current Drugs Targeting HIV-1 Integrase and Reverse Transcriptase-Associated Ribonuclease H Activity: Single and Dual Active Site Inhibitors. Antiviral Chemistry and Chemotherapy. https://doi.org/10.3851/imp2690
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.